Vale S.A. (LON:0LBF)
12.30
-0.02 (-0.18%)
At close: Nov 6, 2025
Vale S.A. Revenue
Vale S.A. had revenue of $55.53B USD in the quarter ending September 30, 2025, with 4.82% growth. This brings the company's revenue in the last twelve months to $202.87B, down -3.90% year-over-year. In the year 2024, Vale S.A. had annual revenue of $206.01B, down -0.99%.
Revenue (ttm)
$202.87B
Revenue Growth
-3.90%
P/S Ratio
1.39
Revenue / Employee
$3.14M
Employees
64,616
Market Cap
39.29B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 206.01B | -2.06B | -0.99% |
| Dec 31, 2023 | 208.07B | -18.44B | -8.14% |
| Dec 31, 2022 | 226.51B | -67.02B | -22.83% |
| Dec 31, 2021 | 293.52B | 87.43B | 42.42% |
| Dec 31, 2020 | 206.10B | 61.46B | 42.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |